3920. INTRAVENOUS THERAPY SERVICES

3920 INTRAVENOUS THERAPY SERVICES 3920.1 If intravenous therapy services are provided, they shall be provided in accordance with the patient's plan of care and administered by a registered nurse or licensed practical nurse who shall have training or experience in intravenous therapy. 3920.2 The intravenous therapy service plan shall include, at a minimum, the following: (a) Type, amount, flow rate, duration, and mode of administration of nutritional formula or intravenous solution; (b) Type, dosage, frequency, duration, and mode of administration of medication; (c) Type and frequency of laboratory tests to be monitored; (d) Information on use of an anticoagulant in connection with intermittent intravenous therapy; and (e) Specific laboratory test limits. 3920.3 Each clinical record shall include, at a minimum, the following information related to intravenous therapy: (a) The intravenous therapy service plan, as ordered by the patient's physician; (b) A copy of the consent form for intravenous therapy executed by the provider of the intravenous therapy product, or a copy of the consent form for intravenous therapy executed by the home care agency, including risks, benefits and alternatives; (c) Documentation of training provided to the patient, patient's caregiver, or other responsible person in intravenous therapy; (d) Information on composition, amount, rate, mode, duration, date, and time of administration of nutrition, medication, and intravenous solution; (e) History of drug allergies and adverse reaction to medication therapy; (f) Date and time of venous access insertion, and type and gauge of needle or catheter used; (g) Information on change of solution, intravenous fluid administration, filter, tubing, and dressings; (h) Observation of the patient and the access site; (i) Laboratory monitoring; (j) Information on all medication administered, including type, dosage, frequency, duration, route of administration, and toxic or side effects; (k) Progress notes at least every thirty (30) calendar days; and (l) A summary report at least every sixty-two (62) calendar days. 3920.4 The first dosage of an antibiotic or chemotherapy shall not be administered by a home care agency, unless an anaphylactic kit is immediately available for administration. 3920.5 The home care agency shall have written policies and procedures concerning intravenous therapy that address the following: (a) Patient selection criteria; (b) Monitoring of patients and emergency care; (c) Availability of care twenty-four (24) hours a day and continuity of care; (d) Preparation and storage of intravenous solutions, special nutrition formulas, and medications; (e) Infection control; (f) Disposal of sharps, catheters, tubing and dressings; (g) Equipment care and maintenance; (h) Administration guidelines, including adverse reaction protocol; (i) Obtaining medical supplies; (j) Blood transfusions; and (k) Adverse reactions. SOURCE: Final Rulemaking published at 51 DCR 2876 (March 19, 2004).